Oric Pharmaceuticals   Report issue

For profit Phase 1
Founded: South San Francisco CA United States (2014)

Organization Overview

First Clinical Trial
2017
NCT03324555
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Oric Pharmaceuticals